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Abstract 
Background: T cells undergo autoimmunization following spinal cord injury (SCI) and play both protective and 
destructive roles during the recovery process. T cell-deficient athymic nude (AN) rats exhibit improved functional 
recovery when compared to immunocompetent Sprague–Dawley (SD) rats following spinal cord transection.
Methods: In the present study, we evaluated locomotor recovery in SD and AN rats following moderate spinal cord 
contusion. To explain variable locomotor outcome, we assessed whole-genome expression using RNA sequencing, in 
the acute (1 week post-injury) and chronic (8 weeks post-injury) phases of recovery.
Results: Athymic nude rats demonstrated greater locomotor function than SD rats only at 1 week post-injury, 
coinciding with peak T cell infiltration in immunocompetent rats. Genetic markers for T cells and helper T cells were 
acutely enriched in SD rats, while AN rats expressed genes for Th2 cells, cytotoxic T cells, NK cells, mast cells, IL-1a, 
and IL-6 at higher levels. Acute enrichment of cell death-related genes suggested that SD rats undergo secondary 
tissue damage from T cells. Additionally, SD rats exhibited increased acute expression of voltage-gated potassium (Kv) 
channel-related genes. However, AN rats demonstrated greater chronic expression of cell death-associated genes and 
less expression of axon-related genes. Immunostaining for macrophage markers revealed no T cell-dependent differ-
ence in the acute macrophage infiltrate.
Conclusions: We put forth a model in which T cells facilitate early tissue damage, demyelination, and Kv channel 
dysregulation in SD rats following contusion SCI. However, compensatory features of the immune response in AN rats 
cause delayed tissue death and limit long-term recovery. T cell inhibition combined with other neuroprotective treat-
ment may thus be a promising therapeutic avenue.
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Background
The role of the immune system in spinal cord injury (SCI) 
is complex, controversial, and relevant to the pathophysi-
ology and treatment of SCI. The literature supports both 
positive and negative effects of the immune system in 
functional recovery after SCI [1, 2]. T cells, which help 
coordinate the immune response, have received substan-
tial attention for their role in SCI.
Systemic spread of central nervous system (CNS) anti-
gens after SCI leads to the formation of autoimmune T 
cells [3, 4] that migrate to the injury site, reaching peak 
accumulation at 1 week post-injury [5, 6]. Helper T cells 
are responsible for macrophage recruitment and acti-
vation, which has been shown to produce focal axonal 
injury and demyelination [7, 8]. These cells also cause 
formation of autoimmune B cells that produce antibodies 
to CNS proteins [9]. Meanwhile, autoimmune cytotoxic 
T cells have been demonstrated to produce significant 
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white matter pathology [10, 11]. Interestingly, while 
myelin-reactive T cells are associated with tissue loss 
and functional impairment [12, 13], these same cells have 
been found to secrete neuroprotective factors and pre-
vent secondary damage to the spinal cord via “protective 
autoimmunity” [14–16].
T cell suppression appears to improve recovery from 
SCI. T cell inhibitors including cyclosporine [17, 18], 
fingolimod [19], and integrin inhibitors [20, 21] have 
been shown to improve neurological function after SCI, 
though their benefit may depend upon injury sever-
ity [22]. T cell-deficient athymic nude (AN) rats dem-
onstrate superior locomotor function after transection 
injury compared to immunocompetent Sprague–Dawley 
(SD) rats [23]. The effects of T cell deficiency in nervous 
system trauma are not limited to SCI; T and B cell-defi-
cient RAG1−/− mice suffer less damage from traumatic 
brain injury [24].
In order to characterize the whole-genome response 
to SCI, researchers have employed microarrays [25, 26] 
and RNA sequencing (RNA-seq) [27]. Gene transcripts 
associated with inflammation, cell death and survival, 
tissue and vascular repair, and nervous system func-
tion and development are most highly represented in 
the injury epicenter [25–29]. The only study to examine 
gene expression differences between AN and SD rats [25] 
employed microarray analysis—a more limited technique 
than RNA-seq—and found only 80 genes that differed 
between the two strains.
In the present study, we assessed (1) locomotor recov-
ery and (2) gene expression in the injury epicenter, fol-
lowing SCI, in both SD and AN rats. We focused on the 
acute (1  week post-injury, when the T cell response is 
maximal) and chronic (8  weeks post-injury) phases of 
recovery. Based on previously findings after spinal cord 
transection, we hypothesized that AN rats would show 
sustained superior locomotor function after injury com-
pared to SD rats. We subsequently used RNA-seq to iden-
tify gene expression differences between the two strains 
that could explain variation in locomotor function.
Methods
Spinal cord injury and postoperative care
All studies were approved by the University of Minnesota 
Institutional Animal Care and Use Committee (IACUC). 
Age-matched adult (16–18 week old) female SD (Hsd:SD, 
N = 15) and AN (Hsd:RH-rnu/rnu, N = 15) rats (Charles 
River, Wilmington, MA, USA) received moderate con-
tusion injury using the Infinite Horizon impactor (Pre-
cision Systems, Lexington, KY, USA). Briefly, animals 
were anesthetized with isoflurane and underwent T8/T9 
laminectomy followed by spinal cord impact at a force 
of 200 kdyn. Animals received buprenorphine (0.05 mg/
kg SC q12 h) for 3 days after surgery to moderate acute 
pain, and amoxicillin (14 g/L in drinking water) for 7 days 
after surgery to prevent urinary tract infection as part of 
standard postoperative care. Urine was expressed manu-
ally twice daily for the first 3 days after surgery and daily 
thereafter until the return of independent urination. Ani-
mals were assigned to either the acute (1 week, N = 5 per 
strain) or chronic (8 weeks, N = 10 per strain) recovery 
phase groups.
Functional assessment
Locomotion was assessed by two observers using the 
Basso, Beattie, and Bresnahan (BBB) scale [30] on the 
second postoperative day and at the end of each week 
following surgery. Animals were on site for at least 
1  week prior to SCI to acclimate to the environment 
and handling by the observers. Raters were trained by a 
researcher (A.P.) with extensive experience using the BBB 
scale. BBB scores were compared between strains via 
repeated-measures analysis of variance.
Tissue preparation
At 1 or 8  weeks after injury, animals were anesthetized 
with ketamine (100  mg/kg IP) and xylazine (10  mg/kg 
IP). For RNA-seq analysis, animals underwent transcar-
dial perfusion with phosphate buffered saline (PBS), and 
a 1-mm spinal cord segment through the injury site was 
harvested and flash-frozen in liquid nitrogen. For histo-
logical analysis, animals underwent transcardial perfu-
sion with 4  % paraformaldehyde. The spinal cord was 
removed and cryoprotected in 30 % sucrose.
Histology
Spinal cord segments from some animals sacrificed 
1 week post-injury (acute recovery group) were frozen in 
OCT compound and sectioned in the parasagittal plane 
at a thickness of 10 μm. Representative sections for each 
spinal cord were selected from the mid-sagittal area and 
immunostained. The following antibodies were used: 
anti-CD68 (1:500, AbD Serotec, Raleigh, NC, USA) for 
macrophages, anti-CD16 (1:100, Abcam, Cambridge, 
United Kingdom) for M1 macrophages, anti-CD163 
(1:50, AbD Serotec) for M2 macrophages, donkey anti-
rabbit IgG (1:1000, ThermoFisher Scientific, Carlsbad, 
CA, USA), and donkey anti-mouse IgG (1:1000, Abcam). 
Negative controls were obtained by omission of the pri-
mary antibody. Immunofluorescent photomicrographs 
were taken from a 1-mm segment centered on the lesion 
epicenter.
Immunofluorescence images were analyzed using 
ImageJ (National Institutes of Health, Bethesda, MD, 
USA). Threshold values for excluding background fluo-
rescence were determined as the 95th percentile of pixel 
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intensity averaged across all negative control images for 
each immunostain. The Analyze Particle function was 
then used to determine the percent of tissue area stained. 
Percent area was compared between AN and SD groups 
via the two-tailed Student’s t test using an alpha value of 
0.05.
RNA extraction and sequencing
RNA extraction, cDNA library creation, and RNA-seq 
were performed with the assistance of the University of 
Minnesota Biomedical Genomics Center staff. RNA was 
extracted from tissue samples using the RNeasy Mini 
Kit (Qiagen, Venlo, The Netherlands). RNA quantity and 
quality were assessed with the Aligent 2100 Bioanalyzer 
(Aligent Technologies, Santa Clara, CA, USA). The poly-
adenylated coding mRNA in each extract (N = 3 for each 
strain–time point combination) was isolated and reverse 
transcribed using random primers. The resulting paired-
end cDNA libraries were subsequently sequenced using 
the HiSeq 2000 (Illumina, San Diego, CA, USA). For each 
sample, at least 40 million paired-end reads of 51 base 
pairs were performed.
Read mapping and transcript identification
Analysis of RNA-seq data was carried out using the Gal-
axy software platform [31–33] hosted by the Minnesota 
Supercomputing Institute. Reads first underwent qual-
ity control assessment with the FastQC tool and adapter 
sequence contamination removal with the CutAdapt tool. 
Because all base positions had first-quartile Phred scores 
greater than 20, trimming with FastQ Trimmer was not 
needed. Reads were subsequently mapped to the Rattus 
norvegicus RN4 reference genome with TopHat (version 
1.5.0) [34] using an empirically determined insertion size 
of 210 base pairs. The mapped reads were assembled 
into transcripts with Cufflinks (version 0.0.6) [35] using 
quartile normalization. Transcriptional datasets for each 
time point were pooled using CuffMerge, and differences 
between strains at each time point were identified with 
CuffDiff. Gene expression differences with a Q value 
(false discovery rate-adjusted P value) less than 0.05 were 
considered to be statistically significant.
Immune and neural marker genes
To measure the presence and activity of both immune and 
neural cells, we first identified a variety of genetic mark-
ers for different cell types belonging to the innate immune 
system, adaptive immune system, and CNS as follows: 
dendritic cell (CD83), macrophage (ITGAM, CD68, 
CD14), M1 macrophage (CD86, RBPJ), M2 macrophage 
(ARG1, CMAF), mast cell (FCER1A, ENPP3, KIT), gran-
ulocyte (CEACAM3, LY6C), NK cell (NCR3, KLRA1, 
KLRA2), T cell (CD3d, CD3e, CD3g), helper T cell (CD4), 
Th1 cell (IL12Rb1, CXCR3, CCR5), Th2 cell (IL1R1, IL2R2, 
IL2RL1, CXCR4, CCR3, CCR4, CCR7, CCR8, TNFRSF8), 
cytotoxic T cell (CD8a, CD8b, GZMB, TIA1), B cell 
(CD19, CD20), neuron (NEFH, RBFOX3), oligodendro-
cyte (APC, MBP, PLP), and astrocyte (GFAP). For each 
cell type, the marker with the greatest abundance (frag-
ments per kilobase of exon per million fragments mapped, 
FPKM) summed over the four conditions (strain–time 
point combinations) was used as the final cell marker.
Broad patterns of differential gene expression
In order to broadly understand strain-dependent differ-
ences in biological processes in response to injury, we 
categorized a subgroup of genes using gene set enrich-
ment analysis (GSEA). Specifically, genes differentially 
expressed between strains in the acute phase only were 
examined via GSEA. First, rat genome database (RGD) 
gene identifiers were converted to gene symbols using 
the DAVID Gene ID Conversion Tool (http://david.abcc.
ncifcrf.gov). Gene symbols for differentially expressed 
genes were then entered into the GSEA utility (http://
www.broadinstitute.org/gsea) and mapped to the Canon-
ical Pathways gene set collection. The 20 most highly 
enriched gene sets were identified.
Investigation of specific pathophysiological processes
To investigate differences in specific processes (e.g. cell 
death) between strains, we identified appropriate gene 
ontology (GO) terms related to those processes (refer to 
“Results” section for a list of all GO terms used). Along 
with these GO terms, we entered genes differentially 
expressed in the acute and/or chronic phases into the 
AmiGO Slimmer tool (http://amigo1.geneontology.org). 
This allowed us to compare gene expression in processes 
of interest between strains at different time points.
Results
Locomotor recovery
A total of 15 AN and 15 SD rats underwent contusive SCI 
at a force of 200 kdyn. The BBB locomotor scores of AN 
and SD rats differed (P = 0.02) at 1 week following injury, 
at which point the mean BBB scores (±1 standard error) 
were 8.5 ± 0.5 and 5.5 ± 0.9, respectively (Fig. 1a). The 
BBB scores of the two strains did not differ at any other 
time point.
Figure  1b shows the time course of the difference 
between BBB scores of AN and SD rats as well as the 
density of the T cell infiltrate in the SD rat injury epi-
center (data used with permission) [5] over the first 
4 weeks after injury. The locomotor advantage of AN rats 
over SD rats at 1 week coincides with the maximal T cell 
infiltrate, and both functional difference and T cell den-
sity decrease gradually thereafter.
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RNA‑seq experimental design
Based upon the locomotor difference between AN and 
SD rats in the acute (1 week post-injury) but not chronic 
(8 weeks post-injury) phase of recovery, we took a multi-
step approach to analysis of RNA-seq data. First, to gain 
a broad understanding of the transcriptional basis of the 
acute locomotor difference, we compared the acute- and 
chronic-phase differential expression profiles to iden-
tify genes that were differentially expressed in the acute 
phase only. We then identified physiological pathways 
that were highly represented among these genes. Sec-
ond, to investigate specific pathophysiological processes 
involved in SCI, we identified genes that were differen-
tially expressed—in the acute and/or chronic phase—and 
associated with select GO terms.
Public data availability
RNA-seq data (raw and processed files) are available in 
the Gene Expression Omnibus (http://www.ncbi.nlm.nih.
gov/geo) under accession number GSE62760.
Quality control
RNA samples sent for sequencing had 1.8–10 ng of RNA 
at a concentration of 92–100 ng/µL and an RNA integrity 
number (RIN) of 9.7–10. For each sample, 40.0–51.6 mil-
lion reads 51 base pairs in length were sequenced. Both 
paired read sets for every sample had a per-base first-quar-
tile Phred quality score greater than 30 for all bases, indicat-
ing a base measurement error less than 0.1 %. Expression 
ranges were highly consistent between samples (Fig. 2).
Differential gene expression
A total of 14,911 genes were identified by RNA-
seq. 14,565 in the acute phase and 14,567 in the chronic 
phase. Read mapping statistics for each sample are sum-
marized in Table 1. Statistical significance for differential 
gene expression was determined based upon the Q value 
(false discovery rate-adjusted P value). Magnitude of dif-
ferential expression was quantified as fold change (FC), 
equal to AN FKPM divided by SD FKPM. Volcano plots 
of statistical significance (−log10Q) versus difference 
magnitude (log2FC) reveal that the magnitude of differen-
tial gene expression was larger in the acute phase (Fig. 3). 
The median absolute value of log2FC for differentially 
expressed genes was 1.27 in the acute phase, compared to 
0.99 in the chronic phase (P < 0.001 for Mann–Whitney 
U test).
Of the 14,911 genes identified by RNA-seq.  11,888 
displayed no differential expression (Fig.  4a). Among 
Fig. 1 Variation in locomotor recovery between AN and SD rats. a Mean BBB locomotor score over time following SCI. Asterisk indicates P < 0.05. 
N = 8 for AN rats; N = 10 for SD rats. Error bars represent ±1 standard error. b Locomotor difference and T cell infiltration. Mean BBB score difference 
between AN and SD rats (left axis) and T cell density (T cells/mm2) in injury epicenter of SD rat (right axis). T cell data is used with permission [5]. Error 
bars represent ±1 standard error
Fig. 2 Expression ranges for individual tissue samples. Box-and-
whisker plot of log(FPKM) for each animal (3-digit identification 
number). Whiskers indicate 1st to 99th percentile; values outside this 
range are not represented. Note that the expression ranges were 
highly consistent between samples
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differentially expressed genes, 999 differed in the acute 
phase only, 888 in the chronic phase only, and 1136 in 
both acute and chronic phases. Most genes that were dif-
ferentially expressed in both acute and chronic phases 
were greater expressed in SD rats in both phases, indi-
cated by log2FC values less than zero (Fig. 4b). Forty-two 
genes were greater expressed in SD rats in one phase and 
AN rats in the other. A complete list of the identified 
genes, expression data, and results of significance testing 
is provided in Additional file 1: Table S1 (as well as in the 
Gene Expression Omnibus; see above).
Immune and neural marker genes
The highest-abundance immune and neural cell marker 
genes were identified and compared between strains 
in the acute and chronic phases (Table  2). Genes cor-
responding to T cells (CD3g) and helper T cells (CD4) 
were enriched in SD rats (relative to AN rats) in the 
acute phase only. In AN rats, Th1 cell marker CXCR4 
was enriched in AN rats in both the acute and chronic 
phases, while cytotoxic T cell marker CD8a was enriched 
in the acute phase only. Gene markers for NK cells 
(KLRA1) and mast cells (KIT) were enriched in AN rats 
in the chronic phase only. Expression of markers for den-
dritic cells (CD83), macrophages (all: CD68; M1: CD86; 
M2: CMAF), granulocytes (Ly6C), Th1 cells (CCR5), and 
B cells (CD19) did not vary by strain. The neurofilament 
gene NEFH was enriched in AN rats in the chronic phase; 
oligodendrocyte (PLP) and astrocyte (GFAP) marker 
genes were not differentially expressed.
Gene set enrichment analysis
The 20 most highly enriched gene sets were identified 
for genes differentially expressed in the acute phase only 
Table 1 Read mapping from RNA-seq output
Phase Strain Animal Total reads Mapped reads % Mapped Genes
Acute AN 714 51,634,511 50,136,688 97.1 13,574
715 44,269,036 43,001,258 97.1 13,471
717 44,842,419 43,542,173 97.1 13,559
SD 618 48,194,423 46,090,448 95.6 14,035
619 39,885,927 38,511,046 96.6 13,610
620 45,447,598 43,769,395 96.3 13,745
Chronic AN 707 44,446,497 42,956,572 96.6 13,763
712 45,858,389 44,358,919 96.7 13,653
713 43,186,929 41,819,751 96.8 13,632
SD 605 49,095,638 47,230,803 96.2 13,861
606 45,671,290 43,873,662 96.1 13,849
608 45,194,438 43,242,894 95.7 13,926
Fig. 3 Volcano plots for differential gene expression in the acute and chronic phases of SCI. Colors represent Q < 0.05 (red) and Q > 0.05 (black) 
for differential expression testing. The overall magnitude of differential gene expression was greater in the acute phase, as evidenced by a larger 
median absolute value of log2FC (1.27 acute versus 0.99 chronic; P < 0.001) for differentially expressed genes. FC fold change (AN FKPM divided by 
SD FKPM). Q, false discovery rate-adjusted P value
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(Table 3). We then manually classified these gene sets into 
five themes: immune system (7 sets), neurons and axons 
(5 sets), GPCR signaling (3 sets), cell transport (3 sets), and 
other (2 sets). For ease of interpretation, percentage of genes 
with FC >1 in the acute period—meaning genes acutely 
enriched in AN rats—is reported below for all gene sets.
Most genes belonging to immune system gene sets 
were greater expressed in AN rats (59–71 % with acute 
FC >1), with the exception of cell adhesion molecules 
(32 % with acute FC >1). Examination of genes belong-
ing to the “immune system” gene set revealed that 
genes for cytokines IL-1a (acute FC = 2.24, Q = 0.01; 
chronic FC  =  1.05, Q  =  0.95) and IL-6 (acute 
FC  =  3.86, Q  =  0.01; chronic FC  =  1.29, Q  =  1.00) 
were among the most AN-enriched immune system-
related genes in the acute phase. Genes belonging to 
neurons and axon gene sets were greater expressed in 
SD rats (12–22 % with acute FC >1). Genes belonging 
to GPCR signaling and cell transport gene sets were 
more frequently enriched in SD rats (41–46  % and 
32–36  % with acute FC >1, respectively). The “other” 
theme consisted of the “cell cycle” and “developmen-
tal biology” gene sets. Cell cycle genes were nearly all 
enriched in AN rats (94  % with acute FC >1), while 
developmental biology genes were predominantly 
enriched in SD rats (22 % with acute FC >1).
Fig. 4 Differential gene expression in the acute and chronic phases of SCI. a Venn diagram depicting number of differentially expressed genes over 
time. b Plot of gene log2FC values in the acute (horizontal axis) and chronic (vertical axis) phases. Colors represent the phase in which genes are dif-
ferentially expressed. The dashed line (y = x) has a slope of 1. FC fold change (AN FKPM divided by SD FKPM)
Table 2 Analysis of cell types via marker genes
FC fold change (AN FKPM divided by SD FKPM); Q, false discovery rate-adjusted P value
System Cell type Marker Acute Chronic
Greater log2FC Q Greater log2FC Q
Innate immune system Dendritic cell CD83 0.14 0.77 −0.02 0.98
Macrophage CD68 0.66 0.12 0.47 0.07
  M1 macrophage CD86 0.50 0.16 −0.18 0.68
  M2 macrophage CMAF 0.46 0.12 0.32 0.18
Mast cell KIT −0.05 0.95 AN 0.57 0.01
Granulocyte Ly6C 0.19 0.91 0.26 0.87
NK cell KLRA1 0.63 0.15 AN 1.20 <0.01
Adaptive immune system T cell CD3g SD −2.37 0.02 −0.88 0.17
  Helper T cell CD4 SD −1.20 <0.01 −0.25 0.36
      Th1 cell CCR5 −0.12 0.83 −0.14 0.72
      Th2 cell CXCR4 AN 0.65 0.02 AN 0.49 0.01
  Cytotoxic T cell CD8a AN 1.39 <0.01 −0.37 0.16
B cell CD19 −1.29 1.00 0.74 1.00
Central nervous system Neuron NEFH −3.31 0.05 SD −1.90 <0.01
Oligodendrocyte PLP −1.27 0.30 −0.21 0.82
Astrocyte GFAP −1.48 0.34 0.00 1.00
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Cell death‑associated genes
We identified cell death-associated genes differentially 
expressed in the acute and/or chronic phases (Table  4). 
Genes associated with the cell death parent GO term 
were acutely enriched in SD rats (39 % with acute FC >1) 
and chronically enriched in AN rats (57 % with chronic 
FC >1). Programmed cell death (202 genes in acute phase 
and 179 genes in chronic phase) was more highly repre-
sented than necrotic cell death (7 genes in acute phase 
and 6 genes in chronic phase). Of note, however, necro-
sis-associated genes were enriched in AN rats in both 
the acute (86 % with acute FC >1) and chronic (83 % with 
chronic FC >1) phases. Genes associated with regulation 
of cell death were acutely enriched in SD rats (39 % with 
acute FC >1) and chronically enriched in AN rats (58 % 
with chronic FC >1). Neuron death-associated genes 
were enriched in SD rats in both acute (21 % with acute 
FC >1) and chronic (41  % with chronic FC >1) phases, 
though less so in the chronic phase. For cell and neu-
ron death at a given time point, the strain with greater 
expression of death-associated genes also had greater 
expression of both positive and negative death regula-
tion-associated genes. 
Voltage‑gated potassium channel‑related genes
We identified differentially expressed genes associated 
with voltage-gated potassium (Kv) channels (Table  4). 
Genes related to Kv channel activity were enriched in SD 
rats in both the acute (4 % with acute FC >1) and chronic 
(4 % with chronic FC >1) phases. Similarly, genes related 
to the Kv channel complex were enriched in SD rats in 
both the acute (5 % with acute FC >1) and chronic (7 % 
with chronic FC >1) phases. One gene (CNTN2) related 
to Kv channel clustering was differentially expressed. 
CNTN2 was differentially expressed in the acute phase 
(acute FC = 0.44, Q < 0.01) but not in the chronic phase 
(chronic FC = 0.98, Q = 0.97).
Histologic assessment of acute macrophage infiltrate
To corroborate our gene expression data, we stained 
spinal cord tissue obtained 1  week post-injury for mac-
rophages (anti-CD68) as well as the M1 (anti-CD16) and 
M2 (anti-CD163) macrophage subtypes. Figure 5 depicts 
the results of fluorescence immunostaining. Percentage 
of tissue area stained did not vary by strain for any mac-
rophage marker (P = 0.19 for CD68, P = 0.85 for CD16, 
and P = 0.71 for CD163).
Table 3 Gene set enrichment analysis (GSEA) of genes differentially expressed in the acute phase only
FC fold change (AN FKPM divided by SD FKPM), Q false discovery rate-adjusted P value
a The 20 most highly enriched gene sets have been manually grouped for conceptual purposes
b The value of −log(Q) is given for the GSEA Q value for each gene set
Themea Gene set Genes % Acutely enriched −log(Q)b
AN (FC >1) SD (FC <1)
Immune system Cell adhesion molecules 25 32 68 Infinite
Cell surface interactions at the vascular wall 17 71 29 10.4
Hematopoietic cell lineage 14 64 36 7.6
Hemostasis 45 67 33 Infinite
Immune system 51 76 24 10.2
Leukocyte trans-endothelial migration 17 59 41 8.7
Platelet activation, signaling, and aggregation 21 62 38 8.1
Neurons and axons Axon guidance (Kegg gene set) 17 12 88 8.1
Axon guidance (Reactome gene set) 29 17 83 12.8
Neuroactive ligand-receptor interaction 23 22 78 7.6
Neuronal system 32 16 84 Infinite
Transmission across chemical synapses 24 17 83 11.5
GPCR signaling Class A1 rhodopsin-like receptors 24 46 54 7.3
GPCR ligand binding 32 41 59 9.9
GPCR signaling 45 42 58 7.6
Cell transport Solute carrier-mediated transmembrane transport 28 36 64 12.4
Transmembrane transport of small molecules 44 32 68 Infinite
Transport of inorganic cations/anions and amino acids/oligopeptides 19 32 68 12.4
Other Cell cycle 17 94 6 8.2
Developmental biology 32 22 78 10.2
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Discussion
In this study, we found that T cell-deficient AN rats pos-
sess greater locomotor function than immunocompetent 
SD rats at 1 week post-SCI, but not at other time points. 
We examined differential gene expression between AN 
and SD rats using RNA-seq to clarify the physiologi-
cal and cellular basis for this functional difference. A 
prior study of gene expression in AN and SD rats after 
SCI found only 80 genes whose expression differed by 
strain [25]. In contrast, we identified 3023 differentially 
expressed genes in the acute (1  week post-injury) and/
or chronic (8 weeks post-injury) phases of SCI. The only 
published report of functional recovery after SCI in AN 
and SD rats found sustained locomotor advantage in 
AN rats following spinal cord transection [23]. We too 
observed functional superiority in AN rats after contu-
sion SCI; however, this advantage was only seen at 1 week 
post-injury.
Effect of T cell deficiency on locomotor recovery
Athymic Nude rats have previously been found to achieve 
greater locomotor function than SD rats after spinal cord 
transection [23]. Whereas SD rats only recovered slight 
movement of hindlimb joints, AN rats on average regained 
extensive movement in one or more hindlimb joints. 
Based upon this finding, we initially hypothesized that 
AN rats would demonstrate superior locomotor function 
over the entire recovery period following moderate spi-
nal cord contusion. In our study, AN rats achieved greater 
BBB locomotor scores (8.5 ± 0.5) than SD rats (5.5 ± 0.9) 
at 1  week post-injury, with weight-supported stepping 
observed in some AN rats but no SD rats. However, this 
functional advantage was transient. The BBB score differ-
ence followed a similar time course to the magnitude of 
the T cell infiltration in immunocompetent SD rats [5]. 
Also in line with difference in functional outcome, greater 
magnitude of differential gene expression was observed in 
the acute phase of recovery than in the chronic phase.
Discrepancy between our results and those of the afore-
mentioned study are likely due to substantial differences 
Table 4 Differential expression within gene ontologies of interest
FC fold change (AN FKPM divided by SD FKPM)
Identifier Gene ontology Acute Chronic
Genes % Enriched Genes % Enriched
AN (FC >1) SD (FC <1) AN (FC >1) SD (FC <1)
GO:0008219 Cell death 221 39 61 196 57 43
  Type of cell death
GO:0012501       Programmed 202 39 61 179 56 44
GO:0070265       Necrotic 7 86 14 6 83 17
GO:0010941   Regulation of cell death 181 39 61 151 58 42
GO:0010942       Positive    regulation 60 42 58 49 65 35
GO:0060548       Negative    regulation 100 38 62 86 53 47
GO:0070997   Neuron death 47 21 79 37 41 59
GO:1901216       Positive    regulation 11 9 91 5 40 60
GO:1901215       Negative    regulation 28 21 79 26 42 58
Voltage-gated potassium channel
GO:0005249   Activity 27 4 96 23 4 96
GO:0008076   Complex 22 5 95 15 7 93
GO:0045163   Clustering 1 0 100 0 n/a n/a
Fig. 5 Histologic assessment of macrophage infiltrate at the acute 
time point (1 week post-injury). The percentage of tissue area 
positively stained for macrophages (CD68), M1 macrophages (CD16), 
or M2 macrophages (CD163) was compared between AN and SD 
rats (N = 4 rats per strain). No significant differences were observed 
(P = 0.19 for CD68, P = 0.85 for CD16, and P = 0.71 for CD163). Error 
bars represent ±1 standard error
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in the mechanism and severity of injury. The authors of 
the prior study conceded that axonal regrowth through 
the transection site was implausible and attributed pro-
longed functional difference to sparing of local neuronal 
connections and central pattern generators [23]. In con-
tusion injury, longitudinal white matter tracts are par-
tially spared [25, 27] and undergo some long-distance 
regeneration in addition to local sprouting [36, 37]. Vari-
ation in the extent and function of surviving tissue may 
help to account for the difference in locomotor recovery 
between AN and SD rats.
Mechanistic basis of altered locomotor recovery
The pathophysiology of SCI is complex, and the pro-
cesses of secondary injury, wound healing, and functional 
recovery are multifactorial [38]. Consequently, compre-
hensive analysis of these processes is difficult, despite the 
use of broad-spectrum techniques such as RNA-seq. We 
have therefore focused on specific, known pathophysi-
ological aspects of SCI that may plausibly be related to T 
cell function.
The differential recovery course between SD and AN 
rats in this study has two possible explanations which 
are not mutually exclusive. One hypothesis is that while 
AN rats recover function more quickly after SCI, they 
are limited in their ultimate recovery in the same ways 
as SD rats. For example, while the absence of T cells may 
contribute to tissue sparing in the acute phase of SCI, 
that tissue may be gradually lost nonetheless. A second 
hypothesis is that AN rats are less vulnerable to tempo-
rary causes of paralysis after SCI, but functional differ-
ences disappear once those effects have subsided. These 
causes may include edema, metabolic dysfunction, and 
Kv channel dysregulation [38].
In our analysis, we compared components of the 
immune response between AN and SD rats. We then 
investigated strain-dependent differences in cell death, 
tissue repair, and Kv channel function. Observed trends 
in gene expression were consistent with involvement of 
all of these processes in differential recovery from SCI. 
We propose a model in which T cells contribute to early 
tissue damage, demyelination, and Kv channel dysregula-
tion in SD rats following contusion SCI, but delayed tis-
sue death limits the long-term recovery of AN rats.
Immune response to SCI in AN rats
The immune response differed substantially between 
AN and SD rats. Among genes differentially expressed 
in the acute phase only, immune system-related genes 
were most highly represented. As expected, T cell and 
helper T cell marker genes were greater expressed in 
SD rats in the acute phase, when the T cell response is 
maximal [5, 6]. However, other T cell subsets appeared 
to be more numerous in AN rats. Cytotoxic T cell marker 
CD8a was enriched in AN rats in the acute phase, while 
Th2 cell marker CXCR4 was enriched in AN rats in both 
acute and chronic phases. Shift from Th1 to Th2 has been 
associated with anti-inflammatory processes [39], so Th2 
enrichment in AN rats may facilitate locomotion in the 
acute period.
The presence and functionality of T cells in AN rats 
remains an open topic of research. The absence of a func-
tional thymus leads to production of fewer, less mature 
“T-like cells” [40]. Culture of T-like cells from AN rats 
yields cytotoxic T cells that recognize foreign antigens 
in  vitro but not in  vivo [41, 42]. T-like cells accumulate 
over time, reaching half of the normal T cell level by 
8–12 months of age [43]. Rats in the present study, how-
ever, were injured at 4 months of age.
Elevated CD8a and CXCR4 expression in AN rats con-
ceivably might not reflect an overabundance of cyto-
toxic T cells and Th2 cells. CD8a is also expressed on 
NK cells [44] and CNS-infiltrating macrophages [45]. 
However, while CD8a was acutely enriched in AN rats, 
NK cell marker KLRA1 was enriched in AN rats in the 
chronic phase only, and macrophage marker CD68 was 
not differentially expressed. CXCR4 is involved in CNS 
development [46], but development-related genes were 
predominantly enriched in SD rats. Thus, increased 
CD8a and CXCR4 expression is consistent with greater 
cytotoxic T cell and Th2 cell infiltration in AN rats. The 
basis of these differences is unclear but may relate to 
complex T cell abnormalities in AN rats.
Highly enriched expression of macrophage-secreted 
cytokines IL-1a and IL-6 in AN rats may reflect com-
pensation for the deficient T cell response. NK cells, 
which are actually more numerous and effective in AN 
rats compared to normal littermates [47], appeared to be 
abundant in the chronic injury site of AN rats and may 
similarly compensate for T cell deficiency. Conversely, 
chronic enrichment of mast cells in AN rats may have 
aided recovery, as mast cells have been found to reduce 
inflammation following SCI [48]. The role of mast cells in 
CNS injury is controversial, however, as mast cells have 
been reported to exacerbate brain injury in ischemic 
stroke [49] and intracerebral hemorrhage [50].
Macrophages, dendritic cells, granulocytes, and B cells 
play important roles in SCI [2, 51], but their respec-
tive marker genes did not vary between AN and SD 
rats. Macrophage recruitment and activation is driven 
by helper T cells, and prior research has found reduced 
macrophage infiltrate in AN rats compared to SD rats 
at 11  weeks post-injury [23]. We therefore performed 
fluorescent immunostaining for macrophage (CD68) and 
macrophage subtype (M1: CD16; M2: CD163) markers 
in the acute injury phase (1 week post-SCI) [52, 53]. We 
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found no strain-dependent differences in the presence of 
any of these markers, consistent with our gene expression 
findings. It should be noted that histological differentia-
tion of M1 and M2 macrophage subtypes is difficult [54] 
and is often done using double-staining methods [55], 
which were not feasible in our case owing to technical 
limitations.
Cell death and tissue repair
Our findings suggest that while SD rats appear to suf-
fer greater acute neuronal death, delayed cell death was 
more common in AN rats. In the acute phase, 61 % of cell 
death-associated genes and 79 % of neuron death-associ-
ated genes were enriched in SD rats; in the chronic phase, 
57 % of cell death-associated genes were enriched in AN 
rats. Only 41  % of neuron death-associated genes were 
chronically enriched in AN rats; this discrepancy sug-
gests that delayed cell death in AN rats may involve less 
loss of neurons than oligodendrocytes and other cells.
The predominant form of cell death appears to have 
been apoptosis rather than necrosis. Of note, necrosis-
associated genes were enriched in AN rats, suggesting 
greater non-immune-mediated cell death. This is con-
sistent with a past report of reduced apoptosis 24 h after 
traumatic brain injury in mice without functional T cells 
compared with immunocompetent mice [24].
Kv channel dysregulation
Demyelination of intact axons uncovers Kv channels 
located in the juxtaparanodal and internodal regions [56, 
57]. Exposure of these channels leads to decreased axonal 
excitability and creates a conduction block [58, 59]. This 
problem is compounded by increased Kv expression [58] 
and redistribution of Kv channels along axons [57, 58].
Conceivably, if T cell activity causes increased cell 
death and demyelination, Kv channel dysregulation may 
contribute to the transient locomotor superiority of AN 
rats after contusion SCI. Consistent with this hypoth-
esis, we found that nearly all differentially expressed Kv 
channel-related genes were enriched in SD rats in both 
the acute and chronic phases. Notably, the Kv channel 
clustering gene CNTN2 was greater expressed in SD rats 
in the acute phase only. CNTN2 (contactin-2, also known 
as TAG-1) is necessary to confine Kv channels to the jux-
taparanodal region [60]. Expression of CNTN2 has been 
found to increase after SCI, and CNTN2 dysfunction is 
associated with worse motor recovery and decreased 
axonal regrowth following injury [61]. Thus, increased 
expression of CNTN2 and Kv channel-related genes may 
occur in response to greater early demyelination in SD 
rats. Delayed demyelination (e.g. due to oligodendrocyte 
death—see above) in AN rats may explain the absence of 
chronic differential expression of CNTN2.
Other contributing factors
Despite greater acute tissue damage, SD rats may have 
undergone greater axonal regrowth. Neurofilament 
expression was strongly elevated in SD rats in the acute 
(FC  =  −3.31, Q  =  0.05) and chronic (FC  =  −1.90, 
Q  <  0.01) phases. Axon guidance-related genes were 
highlighted in GSEA and were highly enriched in SD rats. 
Axon guidance refers to migration of the axon growth 
cone, and like increased neurofilament synthesis, enrich-
ment of axon guidance-related genes suggests increased 
axonal repair in SD rats. Axonal tracing studies are nec-
essary to test this hypothesis. Local sprouting and long-
distance axonal regeneration are known to occur after 
contusion SCI [36, 37]. However, these changes are 
believed to produce little if any functional improvement 
[38] and are therefore unlikely to play a major role here.
Edema is a prominent feature of acute SCI. Vascular 
injury and blood–brain barrier disruption lead to vaso-
genic edema, which contributes to early spinal cord dys-
function [38]. While not measured in the present study, 
the volume of edematous spinal cord tissue—identified 
on MRI as the T2-hyperintense region—has been found 
to be identical in AN and SD rats throughout recovery 
from SCI [25]. Therefore, it seems unlikely that edema is 
responsible for strain-dependent variation in locomotor 
recovery.
As previously stated, we did not assess all pathophysi-
ological processes involved in SCI. Reactive oxygen spe-
cies production, glutamate-mediated excitotoxicity, and 
microvascular dysfunction were less well suited to gene 
expression-based analysis than cell death, tissue repair, 
and Kv channel dysregulation. While the potential rela-
tionship of these unexamined processes to T cell activity 
is unclear, they may nevertheless contribute to the effects 
of T cells on functional recovery.
Differences between the genomes of AN and SD rats 
warrant consideration as well. The AN rat is a homozy-
gous rnu/rnu mutant derived from a colony of hooded 
rats [62, 63]. To our knowledge, there is no published 
comparison of the AN and SD genomes. Functional SCI 
outcomes are known to vary between common labora-
tory rat strains [64, 65], raising the possibility that non-T 
cell-related genes may account for the locomotor differ-
ence observed in the present study. However, the albino 
SD rat demonstrates higher BBB locomotor scores after 
SCI compared to the hooded Wistar and Long-Evans rats 
[64]. This suggests that if background genomic inequal-
ity is present, AN rats are more likely at a disadvantage—
rather than an advantage—compared to SD rats.
Conclusions
Taken together, these findings implicate an 
altered immune response with relevant pro- and 
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anti-inflammatory elements in the altered course of 
locomotor recovery of AN rats. Less damage by T 
cells—coupled with anti-inflammatory effects of Th2 
cells (albeit of questionable functionality) and mast 
cells—may have led to temporary tissue preservation. 
The absence of superior long-term functional recovery 
may be due to compensatory NK cell overabundance and 
macrophage overproduction of inflammatory cytokines 
IL-1a and IL-6. We posit that T cells promote early tissue 
damage, demyelination, and Kv channel dysregulation 
after contusion SCI. However, compensatory features of 
the immune response (e.g. higher NK cell activity and 
increased IL-1a and IL-6 production) may cause delayed 
tissue death in T cell-deficient AN rats, limiting long-
term recovery.
By nature, this work constitutes a broad-spectrum 
analysis of the role of T cell deficiency in SCI. While we 
have identified many promising correlations between 
gene expression and locomotor recovery, these relation-
ships require extensive confirmatory studies. Several 
factors involved in the pathology of SCI were not inves-
tigated in this study and may contribute to the effect of 
T cells on functional recovery. The mechanistic basis for 
certain aspects of the AN immune response (particularly 
increased Th2 and cytotoxic T cell involvement) remains 
unclear, and may serve as a basis for subsequent experi-
ments. Many studies—particularly systematic, quan-
titative immunohistochemistry—are thus required to 
corroborate and expand upon our findings.
Beyond helping to further elucidate the role of T 
cells in recovery from spinal cord trauma, our findings 
may inform future investigation of therapy for SCI. We 
have proposed that the immune consequences of T cell 
deficiency permit sparing of spinal cord tissue that is 
eventually lost in both immunodeficiency and immuno-
competence. Combination therapy with T cell inhibitors 
and other neuroprotective treatment may allow contin-
ued survival of these vulnerable tissues and produce sus-
tained functional recovery.
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